首页> 美国卫生研究院文献>Filaria Journal >Molecular characterization of Babesia microti thioredoxin (BmTrx2) and its expression patterns induced by antiprotozoal drugs
【2h】

Molecular characterization of Babesia microti thioredoxin (BmTrx2) and its expression patterns induced by antiprotozoal drugs

机译:巴比虫微小硫氧还蛋白(BmTrx2)的分子表征和抗原虫药物诱导的表达模式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHuman babesiosis is an infectious disease that is epidemic in various regions all over the world. The predominant causative pathogen of this disease is the intra-erythrocytic parasite Babesia microti. The thioredoxin system is one of the major weapons that is used in the resistance to the reactive oxygen species (ROS) and reactive nitrogen species (RNS) produced by host immune system. In other intra-erythrocytic apicomplexans like the malaria parasite Plasmodium falciparum, anti-oxidative proteins are promising targets for the development of anti-parasitic drugs. However, to date, the sequences and biological properties of thioredoxins and thioredoxin-like molecules of B. microti remain unknown. Understanding the molecular characterization and function of B. microti thioredoxins may help to develop anti-Babesia drugs and controlling babesiosis.
机译:背景技术人类杆状杆菌病是一种传染病,在世界各地都流行。该病的主要致病菌是小红细胞内寄生虫。硫氧还蛋白系统是抵抗宿主免疫系统产生的活性氧(ROS)和活性氮(RNS)的主要武器之一。在诸如疟疾寄生虫恶性疟原虫之类的其他红细胞内apicomplexans中,抗氧化蛋白是开发抗寄生虫药物的有希望的目标。然而,迄今为止,尚不知道小肠芽孢杆菌的硫氧还蛋白和硫氧还蛋白样分子的序列和生物学特性。了解微小芽孢杆菌硫氧还蛋白的分子特征和功能可能有助于开发抗巴贝虫病药物和控制贝氏杆菌病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号